Medtronic 2013 Annual Report Download - page 23

75732me_10K.indd 8 6/28/13 2:13 PM
Table of Contents
Customers and Competitors
The primary medical specialists who use our Structural Heart products are cardiac surgeons and interventional cardiologists. Our
primary competitors in the Structural Heart business are Edwards Lifesciences Corporation, St. Jude, Sorin, Maquet Medical
Systems, which is part of the publicly-listed Swedish group of companies GETINGE AB, and Terumo Medical Corporation.
Endovascular
The Endovascular business is comprised of a comprehensive line of products and therapies to treat aortic disease (such as aneurysms,
dissections, and transections) as well as peripheral vascular disease (PVD). Our products include endovascular stent graft systems,
peripheral stent and angioplasty systems, and carotid embolic protection systems for the treatment of vascular disease outside the
heart.
The following are the principal products offered by our Endovascular business:
Endovascular Stent Grafts. An endovascular stent graft is a minimally invasive device to treat aortic disease such as an aortic
aneurysm, which is a weakened and bulging area in the aorta, the major blood vessel that feeds blood to the body. Our products
are designed to treat aortic aneurysms in either the abdomen (AAA) or thoracic (TAA) regions of the aorta. Our product line
includes a range of endovascular stent grafts and accessories including the market-leading Endurant II abdominal stent graft
systems, and the Valiant Captivia thoracic stent graft systems.
Peripheral Vascular Intervention (PVI). PVI encompasses a variety of procedures to treat patients with PVD, a narrowing or
blockage of vessels outside the heart which impedes blood supply to the brain, kidneys, legs, and other vital organs. Similar to
CAD, PVD is commonly treated with balloon angioplasty which can be followed up with a peripheral stent. Our primary PVI
products include percutaneous angioplasty balloons including the In Pact family of drug-eluting balloons, as well as stents such
as the Complete SE Vascular Stent and the Assurant Cobalt Iliac Stent.
The charts below set forth net sales of our Endovascular products as a percentage of our total net sales for each of the last three
fiscal years:
4%
96%
Fiscal Year 2011
(dollars in millions)
Endovascular
$666
All Other
$14,842
5%
95%
Fiscal Year 2012
(dollars in millions)
All Other
$15,401
Endovascular
$783
5%
95%
Fiscal Year 2013
(dollars in millions)
All Other
$15,723
Endovascular
$867
5%
Customers and Competitors
The primary medical specialists who use our Endovascular products include interventional radiologists, vascular surgeons, cardiac
surgeons, and interventional cardiologists. Our primary competitors in the Endovascular business are Cook, Inc., W. L. Gore &
Associates, Inc., Endologix, Inc., Abbott, Boston Scientific, C.R. Bard, Inc., and Johnson & Johnson, Inc. (Johnson & Johnson).
RESTORATIVE THERAPIES GROUP
Spine
Our Spine business develops, manufactures, and markets a comprehensive line of medical devices and implants used in the treatment
of the spine and musculoskeletal system. Our products and therapies treat a variety of conditions affecting the spine, including
degenerative disc disease, spinal deformity, spinal tumors, fractures of the spine, and stenosis. Our Spine business also provides
biologic solutions for the dental and orthopedic markets.
We offer some of the industry’s broadest lines of devices, including a wide range of sophisticated internal spinal stabilization
devices, instruments, and biomaterials used in the treatment of spinal conditions. Our Spine products are used in spinal fusion of
both the thoracolumbar region, referring to the mid to lower vertebrae, as well as of the cervical region, or upper spine and neck
vertebrae. Products used to treat spinal conditions include rods, pedicle screws, hooks, plates, balloons, cement and interbody
5